BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9450874)

  • 1. Ataxia-telangiectasia without immunodeficiency: novel point mutations within and adjacent to the phosphatidylinositol 3-kinase-like domain.
    Toyoshima M; Hara T; Zhang H; Yamamoto T; Akaboshi S; Nanba E; Ohno K; Hori N; Sato K; Takeshita K
    Am J Med Genet; 1998 Jan; 75(2):141-4. PubMed ID: 9450874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia.
    Laake K; Jansen L; Hahnemann JM; Brondum-Nielsen K; Lönnqvist T; Kääriäinen H; Sankila R; Lähdesmäki A; Hammarström L; Yuen J; Tretli S; Heiberg A; Olsen JH; Tucker M; Kleinerman R; Børresen-Dale AL
    Hum Mutat; 2000 Sep; 16(3):232-46. PubMed ID: 10980530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxia-telangiectasia, an evolving phenotype.
    Chun HH; Gatti RA
    DNA Repair (Amst); 2004; 3(8-9):1187-96. PubMed ID: 15279807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical spectrum of ataxia-telangiectasia in adulthood.
    Verhagen MM; Abdo WF; Willemsen MA; Hogervorst FB; Smeets DF; Hiel JA; Brunt ER; van Rijn MA; Majoor Krakauer D; Oldenburg RA; Broeks A; Last JI; van't Veer LJ; Tijssen MA; Dubois AM; Kremer HP; Weemaes CM; Taylor AM; van Deuren M
    Neurology; 2009 Aug; 73(6):430-7. PubMed ID: 19535770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular perspectives on cancer, the cell cycle and the inherited disorder ataxia-telangiectasia.
    Brown KD; Tagle DA
    Prog Clin Biol Res; 1997; 396():101-13. PubMed ID: 9108592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATM Gene Mutations Detection in Iranian Ataxia-Telangiectasia Patients.
    Sanati MH; Bayat B; Aleyasin A; Atashi Shirazi H; Isaian A; Farhoudi A; Moin M
    Iran J Allergy Asthma Immunol; 2004 Jun; 3(2):59-63. PubMed ID: 17301393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel ATM mutations with ataxia-telangiectasia.
    Liu XL; Wang T; Huang XJ; Zhou HY; Luan XH; Shen JY; Chen SD; Cao L
    Neurosci Lett; 2016 Jan; 611():112-5. PubMed ID: 26628246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low thymic output and reduced heterogeneity of alpha/beta, but not gamma/delta, T lymphocytes in infants with ataxia-telangiectasia.
    Micheli R; Pirovano S; Calandra G; Valotti M; Plebani A; Albertini A; Imberti L
    Neuropediatrics; 2003 Jun; 34(3):165-7. PubMed ID: 12910443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute lymphoblastic leukemia in early childhood as the presenting sign of ataxia-telangiectasia variant.
    Bielorai B; Fisher T; Waldman D; Lerenthal Y; Nissenkorn A; Tohami T; Marek D; Amariglio N; Toren A
    Pediatr Hematol Oncol; 2013 Sep; 30(6):574-82. PubMed ID: 23509889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variants of Nijmegen breakage syndrome and ataxia telangiectasia.
    Weemaes CM; Smeets DF; Horstink M; Haraldsson A; Bakkeren JA
    Immunodeficiency; 1993; 4(1-4):109-11. PubMed ID: 7513225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for pathogenicity of variant ATM Val1729Leu in a family with ataxia telangiectasia.
    Shalash AS; Rösler TW; Salama M; Pendziwiat M; Müller SH; Hopfner F; Höglinger GU; Kuhlenbäumer G
    Neurogenetics; 2021 May; 22(2):143-147. PubMed ID: 33779842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in
    Algahtani H; Shirah B; Algahtani R; Al-Qahtani MH; Abdulkareem AA; Naseer MI
    Int J Neurosci; 2021 Feb; 131(2):206-211. PubMed ID: 32172615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of mutations in ATM, the gene responsible for ataxia telangiectasia in patients with cerebellar ataxia.
    Hassin-Baer S; Bar-Shira A; Gilad S; Galanty Y; Khosravi R; Lossos A; Giladi N; Weitz R; Ben-Zeev B; Goldhammer Y; Shiloh Y
    J Neurol; 1999 Aug; 246(8):716-9. PubMed ID: 10460451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia-telangiectasia presenting with a novel immunodeficiency.
    Perreault S; Bernard G; Lortie A; Le Deist F; Decaluwe H
    Pediatr Neurol; 2012 May; 46(5):322-4. PubMed ID: 22520355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of Ataxia-telangiectasia mutated gene in miniature pigs by somatic cell nuclear transfer.
    Kim YJ; Ahn KS; Kim M; Kim MJ; Park SM; Ryu J; Ahn JS; Heo SY; Kang JH; Choi YJ; Choi SJ; Shim H
    Biochem Biophys Res Commun; 2014 Oct; 452(4):901-5. PubMed ID: 25193705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia.
    Stankovic T; Weber P; Stewart G; Bedenham T; Murray J; Byrd PJ; Moss PA; Taylor AM
    Lancet; 1999 Jan; 353(9146):26-9. PubMed ID: 10023947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very mild presentation in adult with classical cellular phenotype of ataxia telangiectasia.
    Worth PF; Srinivasan V; Smith A; Last JI; Wootton LL; Biggs PM; Davies NP; Carney EF; Byrd PJ; Taylor AM
    Mov Disord; 2013 Apr; 28(4):524-8. PubMed ID: 23143971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype correlations in ataxia telangiectasia patients with
    van Os NJH; Chessa L; Weemaes CMR; van Deuren M; Fiévet A; van Gaalen J; Mahlaoui N; Roeleveld N; Schrader C; Schindler D; Taylor AMR; Van de Warrenburg BPC; Dörk T; Willemsen MAAP
    J Med Genet; 2019 May; 56(5):308-316. PubMed ID: 30819809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical variability in ataxia-telangiectasia.
    Lohmann E; Krüger S; Hauser AK; Hanagasi H; Guven G; Erginel-Unaltuna N; Biskup S; Gasser T
    J Neurol; 2015 Jul; 262(7):1724-7. PubMed ID: 25957637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.